NCT03045653View on ClinicalTrials.gov

Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

February 21, 2019

Study Completion Date

February 21, 2019

Conditions
Breast Cancer Metastatic
Interventions
DRUG

Tamoxifen Oral Product

Tamoxifen 100 mg/d or high-dose Tamoxifen(100 mg/d ) plus chemotherapy

Trial Locations (1)

510060

Sun Yat-sen University, Cancer Center, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT03045653 - Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer | Biotech Hunter | Biotech Hunter